{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:59:40Z","timestamp":1784030380029,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12020-011-9544-4","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T20:14:15Z","timestamp":1318277655000},"page":"89-95","source":"Crossref","is-referenced-by-count":41,"title":["Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus"],"prefix":"10.1007","volume":"41","author":[{"given":"Carmine","family":"Gazzaruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Montalcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Baffero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Garzaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pelissero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Collaviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Grugnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Pujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano B.","family":"Solerte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"9544_CR1","first-page":"347","volume":"44","author":"C Gazzaruso","year":"1999","unstructured":"C. Gazzaruso, A. Garzaniti, D. Geroldi, Genetics and cardiovascular risk: a role for apolipoprotein (a) polymorphism. Cardiologia 44, 347\u2013354 (1999)","journal-title":"Cardiologia"},{"key":"9544_CR2","doi-asserted-by":"crossref","unstructured":"I. Gouni-Berthold, H.K. Berthold, Lipoprotein(a): current perspective. Curr. Vasc. Pharmacol. 2011. [Epub ahead of print]","DOI":"10.2174\/157016111797484071"},{"key":"9544_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0735-1097(99)00541-0","volume":"33","author":"C Gazzaruso","year":"1999","unstructured":"C. Gazzaruso, A. Garzaniti, P. Buscaglia, G. Bonetti, C. Falcone, P. Fratino, G. Finardi, D. Geroldi, Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. J. Am. Coll. Cardiol. 33, 157\u2013163 (1999)","journal-title":"J. Am. Coll. Cardiol."},{"key":"9544_CR4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","volume":"102","author":"J Danesh","year":"2000","unstructured":"J. Danesh, R. Collins, R. Peto, Lipoprotein(a) and coronary heart disease: a meta-analysis of prospective studies. Circulation 102, 1082\u20131085 (2000)","journal-title":"Circulation"},{"key":"9544_CR5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","volume":"168","author":"A Bennet","year":"2008","unstructured":"A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G.D. Lowe, J. Danesh, D. Gudnason, Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch. Intern. Med. 168, 598\u2013608 (2008)","journal-title":"Arch. Intern. Med."},{"key":"9544_CR6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"The Emerging Risk Factors Collaboration","year":"2009","unstructured":"The Emerging Risk Factors Collaboration, Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. JAMA 302, 412\u2013423 (2009)","journal-title":"JAMA"},{"key":"9544_CR7","first-page":"129","volume":"9","author":"P Buscaglia","year":"1996","unstructured":"P. Buscaglia, C. Gazzaruso, Garzaniti, G. Bonetti, A. Porta, A. Negri, G. Vandelli, G. Finardi, P. Fratino, D. Geroldi, Lipoprotein(a) and proliferative diabetic retinopathy in tipe II diabetes mellitus: a role for isoforms with low molecular weight. Diabetes Nutr. Metab. 9, 129\u2013137 (1996)","journal-title":"Diabetes Nutr. Metab."},{"key":"9544_CR8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2337\/diacare.25.8.1418","volume":"25","author":"C Gazzaruso","year":"2002","unstructured":"C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, E. De Amici, D. Geroldi, P. Fratino, Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care 25, 1418\u20131424 (2002)","journal-title":"Diabetes Care"},{"key":"9544_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s005920050095","volume":"35","author":"C Gazzaruso","year":"1998","unstructured":"C. Gazzaruso, A. Garzaniti, P. Buscaglia, G. D\u2019Annunzio, A. Porta, G. Vandelli, R. Lorini, G. Finardi, P. Fratino, D. Geroldi, Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetol. 35, 13\u201318 (1998)","journal-title":"Acta Diabetol."},{"key":"9544_CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1464-5491.2001.00536.x","volume":"18","author":"C Gazzaruso","year":"2001","unstructured":"C. Gazzaruso, A. Garzaniti, C. Falcone, D. Geroldi, G. Finardi, P. Fratino, Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in type 2 diabetic patients and in non diabetic subjects. Diabet. Med. 18, 589\u2013594 (2001)","journal-title":"Diabet. Med."},{"key":"9544_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2840-1-5","volume":"1","author":"C Gazzaruso","year":"2002","unstructured":"C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, P. Fratino, Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc. Diabetol. 1, 5 (2002)","journal-title":"Cardiovasc. Diabetol."},{"key":"9544_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1056-8727(00)00092-1","volume":"14","author":"H Osakawa","year":"2000","unstructured":"H. Osakawa, K. Tokunaga, F. Kawakami, Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus. J. Diabetes Complicat. 14, 307\u2013313 (2000)","journal-title":"J. Diabetes Complicat."},{"key":"9544_CR13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","volume":"83","author":"LL Humprey","year":"2008","unstructured":"L.L. Humprey, R. Fu, K. Rogers, M. Freeman, M. Helfand, Homocysteine level and coronary artery disease incidence: a systematic review and meta-analysis. Mayo Clin. Proc. 83, 1203\u20131212 (2008)","journal-title":"Mayo Clin. Proc."},{"key":"9544_CR14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","volume":"38","author":"N Khandanpour","year":"2009","unstructured":"N. Khandanpour, Y.K. Loke, F.J. Meyer, B. Jennings, M.P. Armon, Homocystein and peripheral arterial disease: systematic review and meta-analysis. Eur. J. Vasc. Endovasc. Surg. 38, 316\u2013322 (2009)","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"9544_CR15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2337\/dc08-0278","volume":"31","author":"SG Bruce","year":"2008","unstructured":"S.G. Bruce, T.K. Young, Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care 31, 1837\u20131841 (2008)","journal-title":"Diabetes Care"},{"key":"9544_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"N. Singh, D.G. Armstrong, B.A. Lipsky, Preventing foot ulcers in patients with diabetes. JAMA 293, 217\u2013228 (2005)","journal-title":"JAMA"},{"key":"9544_CR17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/qjmed\/hcn027","volume":"101","author":"MP Khanolkar","year":"2008","unstructured":"M.P. Khanolkar, S.C. Bain, J.W. Stephens, The diabetic foot. Q. J. Med. 101, 685\u2013695 (2008)","journal-title":"Q. J. Med."},{"key":"9544_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.22.1.157","volume":"22","author":"GE Reiber","year":"1999","unstructured":"G.E. Reiber, L. Vilekyte, E.J. Boyko, M. Del Aguila, D.G. Smith, L.A. Lavery, A.J. Boulton, Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 22, 157\u2013162 (1999)","journal-title":"Diabetes Care"},{"key":"9544_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdiacomp.2003.12.003","volume":"19","author":"DA Luis De","year":"2005","unstructured":"D.A. De Luis, N. Fernandez, M.L. Arranz, R. Aller, O. Izaola, E. Romero, Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes type 2. J. Diabetes Complicat. 19, 42\u201346 (2005)","journal-title":"J. Diabetes Complicat."},{"key":"9544_CR20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-2006-954585","volume":"38","author":"MT Garcia-Unzueta","year":"2006","unstructured":"M.T. Garcia-Unzueta, C. Pesquera, E. Calzada et al., Blood-soluble Fas levels are increate in type 2 diabetica patients with peripheral vascular disease. Horm. Metab. Res. 38, 673\u2013677 (2006)","journal-title":"Horm. Metab. Res."},{"key":"9544_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/1056-8727(94)00055-7","volume":"10","author":"RE Maser","year":"1996","unstructured":"R.E. Maser, D.C. Usher, G.S. DeCherney, Little association of lipid parameters and large sensory nerve fiber function in diabetes mellitus. J. Diabetes Complicat. 10, 54\u201359 (1996)","journal-title":"J. Diabetes Complicat."},{"key":"9544_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2796.1999.00566.x","volume":"246","author":"EK Hoogeven","year":"1999","unstructured":"E.K. Hoogeven, P.J. Kostense, G.D. Valk et al., Hyperhomocysteinemia is not related to risk of distal somatic polyneuropathy: the Hoorn study. J. Intern. Med. 246, 561\u2013566 (1999)","journal-title":"J. Intern. Med."},{"key":"9544_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diabres.2005.06.005","volume":"71","author":"K Unluhizarci","year":"2006","unstructured":"K. Unluhizarci, S. Muhtaroglu, S. Kabak, F. Bayram, F. Kelestimur, Serum lipoprotein(a) levels in patients with diabetic foot lesions. Diabetes Res. Clin. Pract. 71, 119\u2013123 (2006)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"9544_CR24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1534734608322490","volume":"7","author":"EM Schwartzfarb","year":"2008","unstructured":"E.M. Schwartzfarb, P. Romanelli, Hyperhomocysteinemia and lower extremity wounds. Int. J. Low. Extrem. Wounds 7, 126\u2013136 (2008)","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"9544_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dmrr.1061","volume":"26","author":"R Gonzalez","year":"2010","unstructured":"R. Gonzalez, T. Pedro, J.T. Real, S. Martinez-Hervas, M.R. Abellan, R. Lorente, A. Priego, M. Catala, F.J. Chaves, J.F. Ascaso, R. Carmena, Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 26, 115\u2013120 (2010)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"9544_CR26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"The Expert Committee on the diagnosis and classification of diabetes mellitus","year":"1997","unstructured":"The Expert Committee on the diagnosis and classification of diabetes mellitus, Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care 20, 1183\u20131197 (1997)","journal-title":"Diabetes Care"},{"key":"9544_CR27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","volume":"25","author":"G Mancia","year":"2007","unstructured":"G. Mancia, G. De Backer, A. Dominiczak et al., ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J. Hypertens. 25, 1751\u20131762 (2007)","journal-title":"J. Hypertens."},{"key":"9544_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2337\/diabetes.47.3.423","volume":"47","author":"A Giustina","year":"1998","unstructured":"A. Giustina, P. Perini, P. Desenzani, S. Bossoni, P. Ianniello, M. Milani, G. Dav\u00ec, G. Romanelli, Long-term treatment with the dual antithrombotic agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. Diabetes 47, 423\u2013430 (1998)","journal-title":"Diabetes"},{"key":"9544_CR29","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"S. Tesfaye, A.J. Boulton, P.J. Dyck et al., Toronto diabetic neuropathy expert group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diabetes Care 33, 2285\u20132293 (2010)","journal-title":"Diabetes Care"},{"key":"9544_CR30","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2337\/dc10-0763","volume":"33","author":"CH Gibbons","year":"2010","unstructured":"C.H. Gibbons, R. Freeman, A. Veves et al., Diabetic neuropathy: a cross-sectional study of the relationships among test of neurophysiology. Diabetes Care 33, 2629\u20132634 (2010)","journal-title":"Diabetes Care"},{"key":"9544_CR31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972)","journal-title":"Clin. Chem."},{"key":"9544_CR32","first-page":"43","volume":"36","author":"CE Fife","year":"2009","unstructured":"C.E. Fife, D.R. Smart, P.J. Sheffield, H.W. Hopf, G. Hawkins, D. Clarke, Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence. Undersea Hyperb. Med. 36, 43\u201353 (2009)","journal-title":"Undersea Hyperb. Med."},{"key":"9544_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.0000133278.81226.C9","volume":"110","author":"C Gazzaruso","year":"2004","unstructured":"C. Gazzaruso, S. Giordanetti, E. De Amici, G. Bertone, C. Falcone, D. Geroldi, P. Fratino, S.B. Solerte, A. Garzaniti, Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110, 22\u201326 (2004)","journal-title":"Circulation"},{"key":"9544_CR34","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2007.10.069","volume":"51","author":"C Gazzaruso","year":"2008","unstructured":"C. Gazzaruso, S.B. Solerte, A. Pujia, A. Coppola et al., Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with asymptomatic coronary artery disease angiographically proven. A potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51, 2040\u20132044 (2008)","journal-title":"J. Am. Coll. Cardiol."},{"key":"9544_CR35","doi-asserted-by":"crossref","unstructured":"C. Gazzaruso, A. Coppola, T. Montalcini, et al., Screening for asymptomatic coronary artery disease can reduce mortality and morbidity in type 2 diabetic patients. Intern. Emerg. Med. (2011). doi: 10.1007\/s11739-011-0527-5","DOI":"10.1007\/s11739-011-0527-5"},{"key":"9544_CR36","doi-asserted-by":"crossref","unstructured":"C. Gazzaruso, A. Coppola, T. Montalcini, et al., Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine. 2011. doi: 10.1007\/s12020-011-9523-9","DOI":"10.1007\/s12020-011-9523-9"},{"key":"9544_CR37","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/dmrr.834","volume":"24","author":"J Apelqvist","year":"2008","unstructured":"J. Apelqvist, The foot in perspective. Diabetes Metab. Res. Rev. 24, S110\u2013S115 (2008)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"9544_CR38","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1002\/dmrr.848","volume":"24","author":"J Apelqvist","year":"2008","unstructured":"J. Apelqvist, K. Bakker, W.H. van Houtum, N.C. Schaper, on behalf of the International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab. Res. Rev. 24, S181\u2013S187 (2008)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"9544_CR39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3949\/ccjm.77a.10036","volume":"77","author":"JM Abraham","year":"2010","unstructured":"J.M. Abraham, L. Cho, The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Clevel. Clin. J. Med. 77, 911\u2013918 (2010)","journal-title":"Clevel. Clin. J. Med."},{"key":"9544_CR40","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"B.G. Nordestgaard, M.J. Chapman, K. Ray et al., European Atherosclerosis Society Consensus Panel Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 31, 2844\u20132853 (2010)","journal-title":"Eur. Heart J."},{"key":"9544_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/187152906779010764","volume":"6","author":"ML Koschinsky","year":"2006","unstructured":"M.L. Koschinsky, Novel insights into Lp(a) physiology and pathogenicity: more question than answers? Cardiovasc. Hematol. Disord. Drug Targets 6, 267\u2013278 (2006)","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"9544_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2010.08.045","volume":"214","author":"G Ntaios","year":"2011","unstructured":"G. Ntaios, C. Savopoulos, S. Chatzopoulos, D. Mikhailidis, A. Hatzitolios, Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis. Atherosclerosis 214, 11\u201319 (2011)","journal-title":"Atherosclerosis"},{"key":"9544_CR43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12020-010-9329-1","volume":"37","author":"M Erdogan","year":"2010","unstructured":"M. Erdogan, S. Solmaz, M. Canataroglu et al., Plasma thrombin-activable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers. Endocrine 37, 449\u2013454 (2010)","journal-title":"Endocrine"},{"key":"9544_CR44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12020-010-9355-z","volume":"38","author":"K Aydin","year":"2010","unstructured":"K. Aydin, M. Isildak, J. Karakaya, A. Gurlek, Change in amputation predictors in diabetic foot disease: effect of multidisciplinary approach. Endocrine 38, 87\u201392 (2010)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9544-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9544-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9544-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T20:20:27Z","timestamp":1593116427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9544-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9544"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9544-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}